Screener
Amneal Pharmaceuticals, Inc. AMRX Affordable Medicines — Currency translation
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:GoodwillForeignCurrencyTranslationGainLoss.
The source filing: Amneal Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 5:19 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001723128-26-000031
| Line item | Affordable Medicines | Specialty | Av KARE | Total |
|---|---|---|---|---|
| Balance as of December 31, 2024 | $161,659 | $366,312 | $69,465 | $597,436 |
| Currency translation | (1,966) | — | — | (1,966) |
| Balance as of December 31, 2025 | 159,693 | 366,312 | 69,465 | 595,470 |
| Currency translation | (1,971) | — | — | (1,971) |
| Balance as of June 30, 2026 | $157,722 | $366,312 | $69,465 | $593,499 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Amneal Pharmaceuticals, Inc.'s affordable medicines — currency translation?
- Amneal Pharmaceuticals, Inc. (AMRX) reported affordable medicines — currency translation of -$301K in Q2 2026.
- How has Amneal Pharmaceuticals, Inc.'s affordable medicines — currency translation changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s affordable medicines — currency translation decreased by 230.8% year-over-year, from -$91K to -$301K.
- What does affordable medicines — currency translation mean?
- Captures the financial impact of fluctuations in foreign exchange rates on the reported earnings of the Affordable Medicines segment. This metric highlights the sensitivity of the segment's international operations to global currency volatility.
Ask your AI about Amneal Pharmaceuticals, Inc.'s affordable medicines — currency translation.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude